-
1 Comment
Medios AG is currently in a long term downtrend where the price is trading 0.4% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.
Medios AG's total revenue rose by 19.6% to $174M since the same quarter in the previous year.
Its net income has dropped by 0.4% to $2M since the same quarter in the previous year.
Finally, its free cash flow fell by 926.5% to $-46M since the same quarter in the previous year.
Based on the above factors, Medios AG gets an overall score of 2/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | DE000A1MMCC8 |
Sector | Healthcare |
Industry | Medical Distribution |
Market Cap | 331M |
---|---|
PE Ratio | 21.97 |
Target Price | 24.5 |
Beta | 1.17 |
Dividend Yield | None |
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is headquartered in Berlin, Germany.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ILM1.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025